PD-1 Blockade in Mismatch Repair–Deficient, Locally Advanced Rectal Cancer | The NEW ENGLAND JOURNAL Of MEDICINE

Authors: Andrea Cercek, M.D., Melissa Lumish, M.D. https://orcid.org/0000-0003-4173-5567, Jenna Sinopoli, N.P., Jill Weiss, B.A., Jinru Shia, M.D., MichelleLamendola-Essel, D.H.Sc., Imane H. El Dika, M.D., and Luis A. Diaz, Jr., M.D.

BACKGROUND

Neoadjuvant chemotherapy and radiation followed by surgical resection of the rectum is a standard treatment for locally advanced rectal cancer. A subset of rectal cancer is caused by a deficiency in mismatch repair. Because mismatch repair–deficient colorectal cancer is responsive to programmed death 1 (PD-1) blockade in the context of metastatic disease, it was hypothesized that checkpoint blockade could be effective in patients with mismatch repair–deficient, locally advanced rectal cancer.

METHODS

We initiated a prospective phase 2 study in which single-agent dostarlimab, an anti–PD-1 monoclonal antibody, was administered every 3 weeks for 6 months in patients with mismatch repair–deficient stage II or III rectal adenocarcinoma. This treatment was to be followed by standard chemoradiotherapy and surgery. Patients who had a clinical complete response after completion of dostarlimab therapy would proceed without chemoradiotherapy and surgery. The primary end points are sustained clinical complete response 12 months after completion of dostarlimab therapy or pathological complete response after completion of dostarlimab therapy with or without chemoradiotherapy and overall response to neoadjuvant dostarlimab therapy with or without chemoradiotherapy.
PD-1 Blockade in Mismatch Repair–Deficient, Locally Advanced Rectal Cancer

RESULTS

A total of 12 patients have completed treatment with dostarlimab and have undergone at least 6 months of follow-up. All 12 patients (100%; 95% confidence interval, 74 to 100) had a clinical complete response, with no evidence of tumor on magnetic resonance imaging, 18F-fluorodeoxyglucose–positron-emission tomography, endoscopic evaluation, digital rectal examination, or biopsy. At the time of this report, no patients had received chemoradiotherapy or undergone surgery, and no cases of progression or recurrence had been reported during follow-up (range, 6 to 25 months). No adverse events of grade 3 or higher have been reported.

CONCLUSIONS

Mismatch repair–deficient, locally advanced rectal cancer was highly sensitive to single-agent PD-1 blockade. Longer follow-up is needed to assess the duration of response. (Funded by the Simon and Eve Colin Foundation and others; ClinicalTrials.gov number, NCT04165772.)
Locally advanced rectal cancer is typically managed with multimodal therapy, including chemotherapy, radiation, and surgery. Current evidence supports a strategy involving the use of neoadjuvant therapy, in which induction chemotherapy with a fluoropyrimidine in combination with oxaliplatin is followed by chemoradiotherapy and then surgery.1-3 This approach results in a pathological complete response in up to a quarter of patients, but it is associated with marked complications and toxic effects — including bowel, urinary, and sexual dysfunction; infertility; and altered quality of life — in a substantial proportion of patients.4-6 In patients undergoing surgery, resection of the rectum is life-altering and often warrants a permanent diverting colostomy.6,7 Owing to the complications of surgery and the high frequency of pathological complete response, interest in organ-sparing nonoperative management is increasing. The use of clinical complete response that is achieved with neoadjuvant treatment as a surrogate for pathological complete response provides patients with a nonoperative option that results in a survival benefit that is similar to that in patients undergoing surgical resection.8-11
Approximately 5 to 10% of rectal adenocarcinomas are mismatch-repair deficient, and these tumors have been shown to respond poorly to standard chemotherapy regimens, including neoadjuvant chemotherapy in locally advanced rectal cancer.12-14 Immune checkpoint blockade alone has been shown to be highly effective as first-line treatment for patients with mismatch repair–deficient metastatic colorectal cancer, as well as for patients with treatment-refractory disease, with objective response rates of 33 to 55%, clinically significant durability of response, and prolonged overall survival.15-17
On the basis of the benefits seen in the context of metastatic disease, we hypothesized that single-agent programmed death 1 (PD-1) blockade alone might be beneficial in mismatch repair–deficient, locally advanced rectal cancer. To test this hypothesis, we initiated a phase 2 study to investigate the overall response and frequency of sustained clinical complete response to neoadjuvant treatment with dostarlimab, a PD-1 inhibitor, in this patient population.

Skip The Scoop | Seek Understanding

Bannon’s War Room | Evening Edition | Recorded May 26, 2021 | Video: 48 Minutes 58 Seconds

Show Me

Why Did So Many Victorians Try to Speak with the Dead?

Show Me

Dr. Scott Atlas: Lockdowns Not Only a ‘Heinous Abuse’ of Power, They Also Failed to Protect the Elderly | Video: 59 Seconds

Show Me

‘Ignore The CDC’: Johns Hopkins Professor Says Half Of Americans Have ‘Natural Immunity’ | Audio: 9 Minutes 41 Seconds

Show Me

Illinois Dem Offered Activist Taxpayer-Funded Job in Alleged Bid to Clear Primary Field, Court Docs Show

Show Me

May 25, 2021 | Nightly News Rebroadcast | Video: 53 Minutes 11 Seconds

Show Me

Bannon’s War Room | Morning Edition Hour 1 | Recorded May 25, 2021 | Video: 48 Minutes 12 Seconds

Show Me

Bannon’s War Room | Morning Edition Hour 2 | Recorded May 25, 2021 | Video: 48 Minutes 14 Seconds

Show Me

Bannon’s War Room | Evening Edition | Recorded May 25, 2021 | Video: 48 Minutes 58 Seconds

Show Me

When We Think Of An Insurrection, Think The Main Stream Media & Their Partners On The ‘Left’ | Video: 1 Minute 48 Seconds

Show Me

Here Is The Most Feared Man To Both The Left and Right Political Establishment | Vernon Jones | Video: 10 Minutes

Show Me

35 Republican Congressmen Vote Yes On Formation Of January 6th Commission

Show Me

Seemingly Racist and Confused, It’s No Wonder Current Polls Show The Majority Of Americans Do Not Believe Biden Won The 2020 Election, Fair and Square | Video: 1 Minutes 58 Seconds

Show Me

Romney First GOP Senator to Say He Would Back Current Jan. 6 Commission Bill

Show Me

DOCS: BLM Activist Admits Bringing Megaphone To ‘Instigate’ Trump Supporters Inside Capitol Building

Show Me

Judicial Watch Sues DC for Records about the U.S. Capitol Police Shooting Death of Ashli Babbitt in the Capitol Building on January 6, 2021

Show Me

AOC Says She’s in ‘Therapy’ After Capitol Riot: Lawmakers Effectively ‘Served in War’

Show Me

The mob made me do it: U.S. Capitol rioters claim Jan. 6 crowd at fault

Show Me

Jim Acosta Mocks Trump As ‘Mussolini Of Mar-A-Lago,’ Claims GOP Fears Jan. 6 Commission

Show Me

GOP Rep. Meijer: Republicans ‘Playing into’ Pelosi’s Hands by Rejecting 1/6 Commission

Show Me

Disgusting: Politifact Hack Putterman Gaslights Public – Argues Video of Capitol Police Giving Protesters OK to Enter Capitol Is Not What It Seems

Show Me

Antifa Activist Who Sold Footage Of January 6 To CNN, NBC, Had $90,000 Seized By Feds

Show Me

The Left is Obsessed with January 6

Show Me

May 24, 2021 | Nightly News Rebroadcast | Video: 48 Minutes 08 Seconds

Show Me

It’s Not Hypocrisy, The COVID Narrative is a Lie – Michigan Governor Gretchen Whitmer Provides Another Example

Show Me

Another Democrat Violates Her Own Draconian Rule Over The General Public | “They Have Pretty Good Pizza”

Show Me

De Blasio, Cuomo announce more prizes in bid to increase vaccinations

Show Me

Alabama governor signs bill to prohibit vaccine passports

Show Me

Big Brother: Millions Secretly Tracked to Monitor Movements After COVID Vaccine

Show Me

Britain will be free from the Covid pandemic if the current vaccines work as expected, expert says

Show Me

If You’ve Had COVID, Please Don’t Get Vaccinated

Show Me

World’s Supply of Chips Is in Danger Unless Taiwan Gets Vaccines

Show Me

(READ) CDC: Reports of heart inflammation in teens after Covid-19 vaccine

Show Me

Most who are fully vaccinated can skip COVID tests, CDC says

Show Me

COMMON SENSE: Rand Paul Says He’s Not Getting COVID Vax Because He Already Had COVID

Show Me

Bannon’s War Room | Morning Edition Hour 1 | Recorded May 24, 2021 | Video: 48 Minutes 04 Seconds

Show Me

Bannon’s War Room | Morning Edition Hour 2 | Recorded May 24, 2021 | Video: 47 Minutes 54 Seconds

Show Me

Bannon’s War Room | Evening Edition | Recorded May 24, 2021 | Video: 48 Minutes 58 Seconds

Show Me

No Lies Are Perfect … Dr. Yan Vindicated for Wuhan Lab Theory | Does Anyone Believe The Mainstream Media & Political Establishment On Anything Anymore?

Show Me

CDC investigating heart problems in teenagers and young adults after Moderna or Pfizer vaccine

Show Me